FDA pharmacologic class
Anticholinergics
13 medicines are in FDA's class of anticholinergics (anticholinergics): glycopyrrolate (Glycate), dicyclomine, atropine, benztropine, ipratropium (Atrovent), scopolamine (Transderm), methscopolamine, tropicamide (Mydriacyl) and 5 more; 11 combination products also contain one. 12 of the 24 are listed from generic labelers (FDA NDC Directory, October 8, 2026). The lowest pharmacy cost is dicyclomine 20 mg tablet at $0.059 per tablet (NADAC).
Which medicines are anticholinergics?
| Medicine | Brand names | Generic labelers (all forms) | Pharmacy cost | Boxed warning | Shortage | Recalls since 2012 |
|---|---|---|---|---|---|---|
| Glycopyrrolate | Glyrx-Pf, Cuvposa, Glycate | 58 labelers | $1.51 per mL 0.2 mg/mL vial | No | A presentation being discontinued | 27 |
| Dicyclomine | none listed | 43 labelers | $0.059 per tablet 20 mg tablet | No | No current entry | 3 |
| Atropine | none listed | 22 labelers | $7.74 per mL 1% eye drops | No | In shortage | 15 |
| Benztropine | none listed | 23 labelers | $0.0753 per tablet 1 mg tablet | No | A presentation being discontinued | 3 |
| Ipratropium | Atrovent | 23 labelers | $0.111 per mL 0.02% solution | No | No current entry | 1 |
| Atropine and diphenoxylate | Lomotil | 19 labelers | $0.139 per tablet 2.5-0.025 mg tablet | No | No current entry | 2 |
| Scopolamine | Transderm | 11 labelers | $4.34 per patch 1 mg/3 day patch | No | A presentation being discontinued | 2 |
| Albuterol and ipratropium | Combivent | 14 labelers | $0.0787 per mL 0.5-3(2.5) mg/3 mL | No | No current entry | 5 |
| Chlordiazepoxide and clidinium | Librax | 12 labelers | $0.256 per capsule Chlordiazepoxide-clidinium capsule | Yes | No current entry | 2 |
| Methscopolamine | none listed | 5 labelers | $0.608 per tablet 2.5 mg tablet | No | No current entry | 0 |
| Tropicamide | Mydriacyl | 5 labelers | $0.552 per mL 1% eye drops | No | No current entry | 2 |
| Tiotropium | Spiriva | 1 labeler | $11.81 per capsule 18 mcg capsule-inhaler | No | No current entry | 5 |
| Atropine and difenoxin | Motofen | none listed | $6.91 per tablet 1-0.025 mg tablet | No | No current entry | 0 |
| Budesonide and formoterol and glycopyrrolate | Breztri | none listed | $61.41 per gram 160-9-4.8 mcg | No | No current entry | 0 |
| Fluticasone and umeclidinium and vilanterol | Trelegy | none listed | $11.12 per unit 100-62.5-25 | No | No current entry | 2 |
| Umeclidinium | Incruse | none listed | $7.35 per inhaler 62.5 mcg inhaler | No | No current entry | 0 |
| Umeclidinium and vilanterol | Anoro | none listed | $4.95 per inhaler 62.5-25 mcg inhaler | No | No current entry | 1 |
| Aclidinium | Tudorza | none listed | $344.55 per unit 400 mcg inhal | No | No current entry | 0 |
| Aclidinium and formoterol | Duaklir | none listed | n/a | No | No current entry | 0 |
| Formoterol and glycopyrrolate | Bevespi | none listed | $40.86 per gram Bevespi aerosphere inhaler | No | No current entry | 1 |
| Glycopyrrolate and neostigmine methylsulfate | Prevduo | none listed | n/a | No | No current entry | 0 |
| Glycopyrronium | Qbrexza | none listed | n/a | No | No current entry | 0 |
| Olodaterol and tiotropium | Stiolto | none listed | $115.80 per gram 60) | No | No current entry | 0 |
| Revefenacin | Yupelri | none listed | $17.43 per mL 175 mcg/3 mL solution | No | No current entry | 0 |
Source: FDA Established Pharmacologic Class (NDC Directory, openFDA); CMS NADAC of October 7, 2026; FDA shortages and recalls (FDA files October 8, 2026)
What do pharmacies pay?
Each medicine's most widely listed form, per unit, in the NADAC survey: what pharmacies paid, not what a patient pays; strengths differ, so compare like with like.
Source: CMS National Average Drug Acquisition Cost (NADAC) survey, October 7, 2026: what retail pharmacies paid per unit; not a counter price